Harold Landry

Edge Rusher

Age: 28
Free Agency: 2027 (UFA)
Accrued Seasons: 6
  • 2024 Salary Cap Charge: $23,800,000 (9.16% of cap)
  • 2024 Cash Payout: $17,250,000 (6.75% of spending)
  • 2024 Cash to Cap Ratio: 0.72
  • Contract Value: $87,500,000 ($17,500,000 APY)
  • Fully Guaranteed Money: $35,250,000
  • Contract Ranking: 16/234 at EDGE

Current Contract

(UFA, signed 2022)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202226$1,250,000$3,800,000$1,250,000$5,050,0002.4%
2023 📝
March 19: 2024 base salary vests to full guarantee
27$4,000,000$6,550,000$4,000,000$10,550,0004.6%
202428$17,250,000$6,550,000$17,250,000$23,800,0009.2%
202529$17,500,000$6,550,000$0$24,050,0009.3%
202630$17,500,000$6,550,000$0$24,050,0008.5%
Total$57,500,000$30,000,000$22,500,000$87,500,000

Contract Notes

Harold Landry signed a five year contract with the Tennessee Titans on March 11, 2022. Value is $87.5 million with $35.25 million guaranteed at signing. Landry's 2024 base salary is guaranteed for injury at signing and will vest on the 5th day of the 2023 league year.

In 2023 the Titans converted $11 million of Landry's salary to a bonus to create $8.25 million in cap space. His cap number will increase by $2.75 million per year from 2024 to 2026.

Cash Flows

- fully earned money
- unearned or partially earned money
$17.5M
$35M
$52.5M
$70M
$87.5M
20222023202420252026
Cash Due$20,250,000$15,000,000$17,250,000$17,500,000$17,500,000
Running Cash$20,250,000$35,250,000$52,500,000$70,000,000$87,500,000
Career Earnings: $43,018,459
Career APY: $7,169,743
Potential Earnings: $95,268,459
Total Guarantees: $39,493,305
Largest Cash Payment: $20,250,000 (2022)
Largest Cap Number: $24,050,000 (2025)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
TitansDraftedExpired20184$6,733,690$1,683,423$4,243,305$7,768,459115.4%$1,942,115
TitansUFAActive20225$87,500,000$17,500,000$35,250,000$35,250,00040.3%$17,625,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Titans6$43,018,459$7,169,743$23,368,4590.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2018Titans$480,000$744,307$480,000$1,224,3070.6%$3,457,228
2019Titans$786,077$744,307$786,077$1,530,3840.7%$786,077
2020Titans$1,092,154$744,307$0$1,836,4610.8%$1,092,154
2021Titans$2,433,000$744,307$0$3,177,3071.7%$2,433,000
2022Titans$1,250,000$3,800,000$1,250,000$5,050,0002.4%$20,250,000
2023Titans$4,000,000$6,550,000$4,000,000$10,550,0004.6%$15,000,000
2024Titans$17,250,000$6,550,000$17,250,000$23,800,0009.2%$17,250,000
2025Titans$17,500,000$6,550,000$0$24,050,0009.3%$17,500,000
2026Titans$17,500,000$6,550,000$0$24,050,0008.5%$17,500,000
Total$62,291,231$32,977,228$23,766,077$95,268,459$95,268,459

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
2018151056.7%39.4%24204.5345132001000
2019160085.4%5.6%432595312141101200
2020160093.8%0.5%46235.545.510165100000
2021170089.5%2.4%5024128014220001000
2023170064.8%17.8%452410.572.514210000000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$11,857,000$17,500,000
Injury Adjusted$11,857,000$17,500,000
test
OTC Valuation $5.9M $11.7M $17.6M $23.5M $29.4M APY $5.7M $11.3M $17M $22.7M $28.3M $11,201,000 $10,000,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.